logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Satoshi Morita

Graduate School of Medicine

85H-index
1.3KPaper Count
4.0WCitation Count
Published Papers 371
Publication Date
logo
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD
errBreast Cancer Research and Treatment
IF3
err2026-07-08
err0
PREAI
errNorikazu Masuda; Shigehira Saji; Yasuyuki Kojima; Masahiro Kitada; Hiroshi Tada; Tsutomu Iwasa; Kei Koizumi; Tsuguo Iwatani; Yasuaki Sagara; Takashi Kuwayama; Masafumi Shimoda; Tatsunari Sasada; Koichiro Tsugawa; Yoshihiro Kawaguchi; Akihiko Shimomura; Takuhiro Yamaguchi; Hiroki Hasegawa; Shun Osaka; Satoshi Morita; Toshinari Yamashita
errShare
errSave
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer
errBreast Cancer
IF2.9
err2026-06-10
err0
PREAI
errTsuguo Iwatani; Norikazu Masuda; Shigehira Saji; Takuhiro Yamaguchi; Yasuyuki Kojima; Masahiro Kitada; Hiroshi Tada; Tsutomu Iwasa; Kei Koizumi; Hideo Shigematsu; Yasuaki Sagara; Toshitaka Okuno; Yoshie Hasegawa; Eriko Tokunaga; Tadahiko Shien; Uhi Toh; Hiroki Hasegawa; Shun Osaka; Satoshi Morita; Toshinari Yamashita
errShare
errSave
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial
errBreast
IF7.9
err2026-05-23
err0
errOAAI
errTaira, Naruto; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Takahashi, Masato; Yoshinami, Tetsuhiro; Ueno, Takayuki; Toyama, Tatsuya; Takano, Toshimi; Kashiwaba, Masahiro; Tsugawa, Koichiro; Tada, Hiroshi; Hara, Fumikata; Fujisawa, Tomomi; Niikura, Naoki; Morita, Satoshi; Masuda, Norikazu
errShare
errSave
Nanofiber-based platform for quantitative analysis of human oligodendrocyte ensheathment with pharmacological perturbations
errStem Cell Reports
IF5.1
err2026-05-14
err0
errOAAI
errSatoshi Morita; Takayuki Kondo; Keiko Imamura; Yukako Sagara; Kayoko Tsukita; Hisanori Tokuda; Yoshihisa Kaneda; Takayuki Izumo; Yoshihiro Nakao; Haruhisa Inoue
errShare
errSave
A novel quantitative method for CT assessment of bronchiectasis using AI-based airway segmentation and upper limits of normal airway caliber
errRespiratory Research
IF5
err2026-03-16
err0
errOAAI
errNaoya Tanabe; Atsuyasu Sato; Tomoki Maetani; Ryo Sakamoto; Motonari Fukui; Izuru Masuda; Megumi Kanasaki; Tomohiro Handa; Susumu Sato; Satoshi Morita; Toyohiro Hirai
errShare
errSave
Risk Stratification Based on Imaging Findings for Pregnancies With Subamniotic or Subchorionic Hematoma on Placental MRI
errJOURNAL OF MAGNETIC RESONANCE IMAGING
IF3.5
err2026-01-01
err0
PREAI
errHarada, Kumi; Himoto, Yuki; Chigusa, Yoshitsugu; Tomotaki, Seiichi; Kurata, Yasuhisa; Yoshida, Atsushi; Muramatsu, Yuriko; Hidaka, Yu; Morita, Satoshi; Matsumoto, Yuka Kuriyama; Kido, Aki; Kirita, Mitsuhiro; Minamiguchi, Sachiko; Mandai, Masaki; Nakamoto, Yuji
errShare
errSave
Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes
errInternational Journal of Clinical Oncology
IF2.8
err2025-11-26
err0
PREAI
errKazuhiro Ko; Mayu Fukuda; Koji Yamanoi; Nobutaka Hayashi; Hisateru Yasui; Takuma Hayashi; Yoshihiro Yakushijin; Takehiko Tsumura; Atsushi Shirakawa; Chiho Nakashima; Yoshinori Imamura; Chikako Yamauchi; Toshio Shimizu; Takahito Ashihara; Nobuhiro Shibata; Takeshi Kotake; Aya Toyofuku; Taito Miyamoto; Rin Mizuno; Mana Taki; Ryusuke Murakami; Satoshi Morita; Manabu Muto; Masaki Mandai
errShare
errSave
Gene-scale in vitro reconstitution reveals histone acetylation directly controls chromatin architecture
errScience Advances
IF12.5
err2025-11-19
err0
PREAI
errYohsuke T. Fukai; Tomoya Kujirai; Masatoshi Wakamori; Setsuko Kanamura; Lisa Yamauchi; Somayeh Zeraati; Satoshi Morita; Chiharu Tanegashima; Mitsutaka Kadota; Mikako Shirouzu; Hitoshi Kurumizaka; Takashi Umehara; Kyogo Kawaguchi
errShare
errSave
Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study
errInternational Journal of Clinical Oncology
IF2.8
err2025-11-05
err0
PREAI
errTakehiro Tozuka; Yoko Tsukita; Kohei Kushiro; Shinobu Hosokawa; Hitomi Nogawa; Satoshi Arai; Sayo Soda; Daisuke Arai; Kei Takamura; Ryoichi Honda; Kosuke Hamai; Yukiko Namba; Yasutaka Kawai; Takashi Kikuchi; Kensuke Nakazawa; Takayuki Honda; Noriyuki Ebi; Yutaka Yamada; Tomonori Makiguchi; Masahiro Seike; Satoshi Morita; Kunihiko Kobayashi; Hajime Asahina
errShare
errSave
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer
errINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
IF2.8
err2025-11-01
err1
PREAI
errKinugasa, Yusuke; Uehara, Kay; Yamaguchi, Kensei; Saito, Yutaka; Murofushi, Keiko; Sugai, Tamotsu; Ishiguro, Megumi; Ishihara, Soichiro; Ueno, Hideki; Oka, Shiro; Kato, Takeshi; Kanemitsu, Yukihide; Kawakami, Hisato; Kobayashi, Hirotoshi; Sakamoto, Yoshihiro; Shiozawa, Manabu; Shiomi, Akio; Shinozaki, Eiji; Takiyama, Hirotoshi; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Hotta, Kinichi; Matsuda, Keiji; Murata, Kohei; Morita, Satoshi; Yamazaki, Kentaro; Yoshida, Masahiro; Yamaguchi, Naohiko; Kagawa, Hiroyasu; Yamauchi, Shinichi; Ajioka, Yoichi
errShare
errSave
Age-Related Associations of Blood Pressure and Arterial Stiffness with Retinal Arterial Structure
errOphthalmology Science
IF4.6
err2025-10-02
err0
errOAAI
errRan Xiang; Yuki Muraoka; Takahiro Kogo; Yu Hidaka; Yuki Mori; Masayuki Hata; Masahiro Miyake; Satoshi Morita; Yasuharu Tabara; Fumihiko Matsuda; Akitaka Tsujikawa
errShare
errSave
Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients
errALLERGOLOGY INTERNATIONAL
IF6.7
err2025-10-01
err2
errOAAI
errKambe, Naotomo; Inoue, Norimitsu; Ueki, Yoko; Zhou, Yuyi; Yonekura, Satoru; Katsuo, Kosuke; Nakamizo, Satoshi; Tsujimoto, Hiroshi; Ohtani, Katsuki; Yoshifuji, Hajime; Jo, Tomoyasu; Izawa, Kazushi; Yamamoto, Mayuko; Takemura, Koji; Kagami, Shin-ichiro; Kawahara, Yoshie; Amino, Yoko; Ibi, Yumiko; Morita, Satoshi; Kanazawa, Nobuo
errShare
errSave
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial
errThe Lancet Respiratory Medicine
IF32.8
err2025-09-28
err0
PREAI
errTetsuhiko Asao; Yu Saida; Satoshi Watanabe; Akira Kisohara; Kazuma Kishi; Ryo Morita; Taku Nakagawa; Yoko Tsukita; Naoki Furuya; Taichi Miyawaki; Nobuhisa Ishikawa; Tadaaki Yamada; Takahiro Tanaka; Satoshi Morita; Toshiaki Kikuchi; Makoto Maemondo; Kunihiko Kobayashi
errShare
errSave
A Phase 2 study of osimertinib in combination with platinum-pemetrexed in patients with uncommon epidermal growth factor receptor-mutated advanced non-small cell lung cancer (NEJ067/OPAL2)
errClinical Lung Cancer
IF3.3
err2025-08-26
err0
PREAI
errDaisuke Morinaga; Megumi Furuta; Satoshi Morita; Eisaku Miyauchi; Kunihiko Kobayashi; Makoto Maemondo; Hajime Asahina
errShare
errSave
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L)
errLung Cancer
IF4.4
err2025-06-29
err0
errOAAI
errMotoko Tachihara; Hiroyasu Shoda; Yuki Akazawa; Takayo Ota; Masahide Oki; Yuki Sato; Shunichi Sugawara; Satoshi Ikeda; Toshihide Yokoyama; Hiroyasu Kaneda; Shoichi Itoh; Akihiro Bessho; Nobuyuki Katakami; Satoshi Morita; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
errShare
errSave
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies
errBreast Cancer
IF2.9
err2025-06-25
err0
PREAI
errAya Imai; Ryo Tsunashima; Yu Hidaka; Sae Kitano; Chikage Kato; Akira Watanabe; Midori Morita; Koichi Sakaguchi; Yoshiaki Sota; Masahiko Suzuki; Takayuki Kinoshita; Seiichi Imanishi; Masahiro Oikawa; Yoshihiko Kamada; Ken-ichi Ito; Takaaki Oba; Shin Takayama; Fumine Tsukamoto; Mina Takahashi; Yutaka Hatanaka; Naoto T. Ueno; Kenzo Shimazu; Satoshi Morita; Yasuto Naoi
errShare
errSave
Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor–positive, HER2‑negative advanced or metastatic breast cancer
errBreast Cancer
IF2.9
err2025-06-23
err0
errOAAI
errTetsuhiro Yoshinami; Yuko Takano; Yukinori Ozaki; Yukiko Kajiwara; Mitsugu Yamamoto; Ken-ichi Watanabe; Masami Tsukabe; Fumie Fujisawa; Shigenori E. Nagai; Nobuhiro Shibata; Chiya Oshiro; Hiroko Bando; Nobuyuki Tsunoda; Kazuhiko Yamagami; Kei Koizumi; Masahiro Takada; Naoko Toriguchi; Nobuyuki Sekine; Tsutomu Kawaguchi; Shigehira Saji; Yasuaki Sagara; Satoshi Morita; Norikazu Masuda
errShare
errSave
Prediction of successful labor induction using 15-hydroxyprostaglandin dehydrogenase in cervicovaginal fluid
errAmerican Journal of Obstetrics and Gynecology
IF8.4
err2025-06-19
err0
errOAAI
errYusuke Ueda; Haruta Mogami; Yuki Tomono; Masato Kurokawa; Yoshitsugu Chigusa; Satoshi Morita; Eiji Kondoh
errShare
errSave
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis
errLung Cancer
IF4.4
err2025-05-27
err0
errOAAI
errToshiya Fujisaki; Eisaku Miyauchi; Gen Kida; Yu Miura; Kana Watanabe; Hironori Ashinuma; Motohiro Tamiya; Hajime Kikuchi; Daisuke Arai; Satoshi Takahashi; Ken Masuda; Ayako Takigami; Yoshiaki Nagai; Taichi Miyawaki; Yukari Tsubata; Akira Nakao; Ken Masubuchi; Kazuhiro Nishiyama; Satoshi Watanabe; Satoshi Morita; Makoto Maemondo
errShare
errSave
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
errBREAST CANCER
IF2.9
err2025-05-20
err0
errOAAI
errYoshinami, Tetsuhiro; Takano, Yuko; Ozaki, Yukinori; Kajiwara, Yukiko; Yamamoto, Mitsugu; Watanabe, Ken-ichi; Tsukabe, Masami; Fujisawa, Fumie; Nagai, Shigenori E.; Shibata, Nobuhiro; Oshiro, Chiya; Bando, Hiroko; Tsunoda, Nobuyuki; Yamagami, Kazuhiko; Koizumi, Kei; Takada, Masahiro; Toriguchi, Naoko; Sekine, Nobuyuki; Kawaguchi, Tsutomu; Saji, Shigehira; Sagara, Yasuaki; Morita, Satoshi; Masuda, Norikazu
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Masatoshi Kudo
H-index: 143 · Papers: 2.8K
T
Tony Mok
H-index: 131 · Papers: 1.1K
O
Osamu Takeuchi
H-index: 119 · Papers: 500
Y
Yukio Ando
H-index: 119 · Papers: 5.1K
Y
Yasushi Yatabe
H-index: 116 · Papers: 1.2K
View more